Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · Real-Time Price · USD
5.14
-0.16 (-3.02%)
At close: Aug 13, 2025, 4:00 PM
5.19
+0.05 (0.97%)
Pre-market: Aug 14, 2025, 8:43 AM EDT
Alterity Therapeutics Employees
Alterity Therapeutics had 10 employees as of June 30, 2024. The number of employees decreased by 1 or -9.09% compared to the previous year.
Employees
10
Change (1Y)
-1
Growth (1Y)
-9.09%
Revenue / Employee
$230,490
Profits / Employee
-$1,224,681
Market Cap
78.35M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ATHE News
- 15 days ago - Appendix 4C – Q4 FY25 Quarterly Cash Flow Report - GlobeNewsWire
- 17 days ago - Alterity Therapeutics Reports Positive Topline Data from Open-Label Phase 2 Clinical Trial of ATH434 in Multiple System Atrophy - GlobeNewsWire
- 21 days ago - Alterity Therapeutics Announces Publication on Novel MRI Endpoint from the bioMUSE Natural History Study - GlobeNewsWire
- 7 weeks ago - Alterity Therapeutics to Provide Corporate Update in Fireside Chat - GlobeNewsWire
- 3 months ago - Alterity Therapeutics Prominently Featured at the International MSA Congress - GlobeNewsWire
- 3 months ago - Alterity Therapeutics Announces Multiple Oral and Poster Presentations to be Featured at the International MSA Congress - GlobeNewsWire
- 3 months ago - Alterity Therapeutics Granted U.S. FDA Fast Track Designation for ATH434 to Treat Multiple System Atrophy - GlobeNewsWire
- 3 months ago - Appendix 4C – Q3 FY25 Quarterly Cash Flow Report - GlobeNewsWire